Multiple Sclerosis Research Repository

1. “Interferons in relapsing remitting multiple sclerosis: a systematic review”: Graziella Filippini et al

-recombinant interferons slightly reduce the number of patients who have exacerbations during first year of treatment.  Their clinical effect beyond 1 year is uncertain and new trials are needed to assess their long-term effectiveness and side-effects